Cargando…

Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain

Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández de Larrea-Baz, Nerea, Michel, Angelika, Romero, Beatriz, Pérez-Gómez, Beatriz, Moreno, Victor, Martín, Vicente, Dierssen-Sotos, Trinidad, Jiménez-Moleón, José J., Castilla, Jesús, Tardón, Adonina, Ruiz, Irune, Peiró, Rosana, Tejada, Antonio, Chirlaque, María D., Butt, Julia A., Olmedo-Requena, Rocío, Gómez-Acebo, Inés, Linares, Pedro, Boldo, Elena, Castells, Antoni, Pawlita, Michael, Castaño-Vinyals, Gemma, Kogevinas, Manolis, de Sanjosé, Silvia, Pollán, Marina, del Campo, Rosa, Waterboer, Tim, Aragonés, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447227/
https://www.ncbi.nlm.nih.gov/pubmed/28611733
http://dx.doi.org/10.3389/fmicb.2017.00888
_version_ 1783239285118337024
author Fernández de Larrea-Baz, Nerea
Michel, Angelika
Romero, Beatriz
Pérez-Gómez, Beatriz
Moreno, Victor
Martín, Vicente
Dierssen-Sotos, Trinidad
Jiménez-Moleón, José J.
Castilla, Jesús
Tardón, Adonina
Ruiz, Irune
Peiró, Rosana
Tejada, Antonio
Chirlaque, María D.
Butt, Julia A.
Olmedo-Requena, Rocío
Gómez-Acebo, Inés
Linares, Pedro
Boldo, Elena
Castells, Antoni
Pawlita, Michael
Castaño-Vinyals, Gemma
Kogevinas, Manolis
de Sanjosé, Silvia
Pollán, Marina
del Campo, Rosa
Waterboer, Tim
Aragonés, Nuria
author_facet Fernández de Larrea-Baz, Nerea
Michel, Angelika
Romero, Beatriz
Pérez-Gómez, Beatriz
Moreno, Victor
Martín, Vicente
Dierssen-Sotos, Trinidad
Jiménez-Moleón, José J.
Castilla, Jesús
Tardón, Adonina
Ruiz, Irune
Peiró, Rosana
Tejada, Antonio
Chirlaque, María D.
Butt, Julia A.
Olmedo-Requena, Rocío
Gómez-Acebo, Inés
Linares, Pedro
Boldo, Elena
Castells, Antoni
Pawlita, Michael
Castaño-Vinyals, Gemma
Kogevinas, Manolis
de Sanjosé, Silvia
Pollán, Marina
del Campo, Rosa
Waterboer, Tim
Aragonés, Nuria
author_sort Fernández de Larrea-Baz, Nerea
collection PubMed
description Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to ≥4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71–1.16). Among H. pylori seropositive subjects, seropositivity to Cagδ showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.
format Online
Article
Text
id pubmed-5447227
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54472272017-06-13 Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain Fernández de Larrea-Baz, Nerea Michel, Angelika Romero, Beatriz Pérez-Gómez, Beatriz Moreno, Victor Martín, Vicente Dierssen-Sotos, Trinidad Jiménez-Moleón, José J. Castilla, Jesús Tardón, Adonina Ruiz, Irune Peiró, Rosana Tejada, Antonio Chirlaque, María D. Butt, Julia A. Olmedo-Requena, Rocío Gómez-Acebo, Inés Linares, Pedro Boldo, Elena Castells, Antoni Pawlita, Michael Castaño-Vinyals, Gemma Kogevinas, Manolis de Sanjosé, Silvia Pollán, Marina del Campo, Rosa Waterboer, Tim Aragonés, Nuria Front Microbiol Microbiology Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to ≥4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71–1.16). Among H. pylori seropositive subjects, seropositivity to Cagδ showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified. Frontiers Media S.A. 2017-05-29 /pmc/articles/PMC5447227/ /pubmed/28611733 http://dx.doi.org/10.3389/fmicb.2017.00888 Text en Copyright © 2017 Fernández de Larrea-Baz, Michel, Romero, Pérez-Gómez, Moreno, Martín, Dierssen-Sotos, Jiménez-Moleón, Castilla, Tardón, Ruiz, Peiró, Tejada, Chirlaque, Butt, Olmedo-Requena, Gómez-Acebo, Linares, Boldo, Castells, Pawlita, Castaño-Vinyals, Kogevinas, de Sanjosé, Pollán, del Campo, Waterboer and Aragonés. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Fernández de Larrea-Baz, Nerea
Michel, Angelika
Romero, Beatriz
Pérez-Gómez, Beatriz
Moreno, Victor
Martín, Vicente
Dierssen-Sotos, Trinidad
Jiménez-Moleón, José J.
Castilla, Jesús
Tardón, Adonina
Ruiz, Irune
Peiró, Rosana
Tejada, Antonio
Chirlaque, María D.
Butt, Julia A.
Olmedo-Requena, Rocío
Gómez-Acebo, Inés
Linares, Pedro
Boldo, Elena
Castells, Antoni
Pawlita, Michael
Castaño-Vinyals, Gemma
Kogevinas, Manolis
de Sanjosé, Silvia
Pollán, Marina
del Campo, Rosa
Waterboer, Tim
Aragonés, Nuria
Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
title Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
title_full Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
title_fullStr Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
title_full_unstemmed Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
title_short Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
title_sort helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in spain
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447227/
https://www.ncbi.nlm.nih.gov/pubmed/28611733
http://dx.doi.org/10.3389/fmicb.2017.00888
work_keys_str_mv AT fernandezdelarreabaznerea helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT michelangelika helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT romerobeatriz helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT perezgomezbeatriz helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT morenovictor helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT martinvicente helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT dierssensotostrinidad helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT jimenezmoleonjosej helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT castillajesus helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT tardonadonina helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT ruizirune helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT peirorosana helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT tejadaantonio helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT chirlaquemariad helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT buttjuliaa helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT olmedorequenarocio helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT gomezaceboines helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT linarespedro helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT boldoelena helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT castellsantoni helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT pawlitamichael helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT castanovinyalsgemma helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT kogevinasmanolis helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT desanjosesilvia helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT pollanmarina helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT delcamporosa helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT waterboertim helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain
AT aragonesnuria helicobacterpyloriantibodyreactivitiesandcolorectalcancerriskinacasecontrolstudyinspain